AI in healthcare software: where the safe value is, and where the bar is much higher

Start with the administrative burden

Clinical documentation, coding support, prior authorisation paperwork, referral triage and appointment scheduling consume a very large share of clinician and staff time. Reducing that time has direct value and does not touch clinical judgement.

Ambient documentation, capturing a consultation and drafting notes for clinician review, has become the flagship example. The design principle that makes it acceptable is that a clinician reviews and signs everything, so the AI drafts and a human decides.

The regulatory line

When software influences diagnosis or treatment decisions, it may be regulated as a medical device, bringing clinical validation, quality management and regulatory submission into scope. That is a fundamentally different project with a different timeline and budget.

The boundary is not always obvious, and it deserves proper regulatory advice early. Building a promising clinical decision support tool and discovering the pathway afterwards is an expensive way to learn where the line sits.

Drafting a note a clinician signs is a productivity feature. Suggesting what the note should conclude is a different regulatory universe.

Protected health information

PHI handling constrains architecture directly: where processing may occur, which providers are acceptable, what agreements must be in place, and what must be logged. In the US that means HIPAA obligations, with equivalents elsewhere.

Settle this before design. The answer determines whether hosted models are available at all, and discovering that they are not after building on them is a rewrite rather than a configuration change. Our healthcare testing guide covers the verification side.

Accuracy expectations and failure costs

The asymmetry between error types is sharper here than almost anywhere. Missing something clinically significant and flagging something benign have very different consequences, and thresholds must be set with clinical input rather than optimised for aggregate accuracy.

Bias deserves specific attention, since models trained on historical healthcare data can reproduce documented disparities in care. Evaluating performance across demographic groups is a safety requirement, not a reporting exercise.

Clinical workflow is the adoption test

A feature that adds clicks or interrupts a consultation will not be used regardless of accuracy. Integration into the existing record system and the clinician's actual flow is usually the harder half of the delivery.

Involve clinicians throughout, not at the end. They will tell you within minutes which parts of the workflow can absorb a change and which cannot, and that knowledge is not obtainable any other way. Our healthcare practice works this way by default.

Frequently asked questions

Is clinical AI a regulated medical device?

It can be, depending on whether it influences diagnosis or treatment and on jurisdiction. Administrative and documentation tools generally are not. Get regulatory advice on your specific feature early.

Can PHI be sent to hosted model providers?

Only under appropriate agreements and configurations, and some organisations decide not to at all. Establish your position before choosing an architecture.

What is the safest place to start?

Documentation and administrative workflow, with clinician review of every output. High value, contained risk, and it builds organisational confidence.

Building AI into a clinical or healthcare product? A free 30-minute consultation covers where the regulatory line sits and what to build first.